S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
Log in

Canopy Growth Stock Forecast, Price & News

-1.23 (-3.55 %)
(As of 01/15/2021 08:00 PM ET)
Today's Range
Now: $33.39
50-Day Range
MA: $26.71
52-Week Range
Now: $33.39
Volume608,040 shs
Average Volume9.13 million shs
Market Capitalization$12.43 billion
P/E RatioN/A
Dividend YieldN/A
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis for recreational and medical purposes primarily in Canada, the United States, Germany, and the United Kingdom. It operates through two segments, Cannabis, Hemp and Other Consumer Products; and Canopy Rivers. The company's products include dried cannabis flowers, oils and concentrates, and softgel capsules. It offers its products under the Tweed, Quatreau, Deep Space, Spectrum Therapeutics, First & Free, TWD, This Works, BioSteel, DNA Genetics CraftGrow, Tokyo Smoke, DOJA, Van der Pop, and Bean & Bud brands. The company also provides growth capital and a strategic support platform that pursues investment opportunities in the global cannabis sector. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada and NHL Alumni Association to examine the efficacy of CBD-based therapies as part of the mitigation of persistent post-concussion symptoms. As of February 14, 2020, it operated 28 cannabis retail stores under the Tweed or Tokyo Smoke name. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
Canopy Growth logo


Overall MarketRank

0.87 out of 5 stars

Analyst Opinion: 1.1Community Rank: 3.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Medicinals & botanicals
Current SymbolNASDAQ:CGC
Phone855 558 9333



Sales & Book Value

Annual Sales$297.34 million
Cash Flow$1.64 per share
Book Value$10.97 per share


Net Income$-993,370,000.00
Net Margins-312.84%


Market Cap$12.43 billion
Next Earnings Date2/12/2021 (Estimated)
-1.23 (-3.55 %)
(As of 01/15/2021 08:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CGC News and Ratings via Email

Sign-up to receive the latest news and ratings for CGC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Canopy Growth (NASDAQ:CGC) Frequently Asked Questions

How has Canopy Growth's stock price been impacted by COVID-19?

Canopy Growth's stock was trading at $13.35 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, CGC shares have increased by 150.1% and is now trading at $33.39.
View which stocks have been most impacted by COVID-19

Is Canopy Growth a buy right now?

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Canopy Growth in the last twelve months. There are currently 3 sell ratings, 9 hold ratings, 3 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" Canopy Growth stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CGC, but not buy additional shares or sell existing shares.
View analyst ratings for Canopy Growth
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Canopy Growth?

Wall Street analysts have given Canopy Growth a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Canopy Growth wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Canopy Growth's next earnings date?

Canopy Growth is scheduled to release its next quarterly earnings announcement on Friday, February 12th 2021.
View our earnings forecast for Canopy Growth

How were Canopy Growth's earnings last quarter?

Canopy Growth Co. (NASDAQ:CGC) released its quarterly earnings data on Monday, November, 9th. The company reported $0.16 earnings per share for the quarter, beating analysts' consensus estimates of ($0.23) by $0.39. The company had revenue of $113.20 million for the quarter, compared to the consensus estimate of $87.71 million. Canopy Growth had a negative return on equity of 13.11% and a negative net margin of 312.84%.
View Canopy Growth's earnings history

What price target have analysts set for CGC?

16 Wall Street analysts have issued 12 month price objectives for Canopy Growth's shares. Their forecasts range from $21.10 to $40.00. On average, they expect Canopy Growth's share price to reach $31.51 in the next twelve months. This suggests that the stock has a possible downside of 5.6%.
View analysts' price targets for Canopy Growth
or view Wall Street analyst' top-rated stocks.

Who are some of Canopy Growth's key competitors?

Who are Canopy Growth's key executives?

Canopy Growth's management team includes the following people:
  • Mr. David Eric Klein, CEO & Director (Age 56, Pay $2.23M)
  • Mr. Rade Nikola Kovacevic, Pres & Chief Product Officer (Age 34, Pay $642.6k)
  • Mr. Michael Alan Lee, Exec. VP & CFO (Age 47, Pay $824.95k)
  • Mr. Thomas Carlton Stewart, VP & Chief Accounting Officer (Age 38, Pay $344.36k)
  • Mr. Phillip Stephen Shaer, Chief Legal Officer (Age 46, Pay $267.83k)
  • Mr. Timothy Rob Saunders, Strategic Advisor (Age 59, Pay $328.43k)
  • Mr. Andrew MacCorquodale, Interim COO & VP of Operations Transformation
  • Mr. Thomas Shipley IV, Sr. VP of Quality Assurance & Chief Science Officer (Age 31)
  • Ms. Holly Lukavsky, Chief HR Officer
  • Jason Green, Head of Agriculture - Hemp Division

What is Canopy Growth's stock symbol?

Canopy Growth trades on the NASDAQ under the ticker symbol "CGC."

Who are Canopy Growth's major shareholders?

Canopy Growth's stock is owned by a number of institutional and retail investors. Top institutional investors include NuWave Investment Management LLC (0.01%), Tatro Capital LLC (0.00%), Sowell Financial Services LLC (0.00%), TRUE Private Wealth Advisors (0.00%), Patriot Financial Group Insurance Agency LLC (0.00%) and Global Retirement Partners LLC (0.00%). Company insiders that own Canopy Growth stock include Phillip Stephen Shaer, Rade Nikola Kovacevic and Tomas Iv Shipley.
View institutional ownership trends for Canopy Growth

Which major investors are buying Canopy Growth stock?

CGC stock was purchased by a variety of institutional investors in the last quarter, including NuWave Investment Management LLC, Tatro Capital LLC, Global Retirement Partners LLC, Patriot Financial Group Insurance Agency LLC, TRUE Private Wealth Advisors, and Sowell Financial Services LLC.
View insider buying and selling activity for Canopy Growth
or or view top insider-buying stocks.

How do I buy shares of Canopy Growth?

Shares of CGC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Canopy Growth's stock price today?

One share of CGC stock can currently be purchased for approximately $33.39.

How big of a company is Canopy Growth?

Canopy Growth has a market capitalization of $12.43 billion and generates $297.34 million in revenue each year. The company earns $-993,370,000.00 in net income (profit) each year or $1.32 on an earnings per share basis. Canopy Growth employs 4,434 workers across the globe.

What is Canopy Growth's official website?

The official website for Canopy Growth is www.canopygrowth.com.

How can I contact Canopy Growth?

Canopy Growth's mailing address is 1 HERSHEY DRIVE, SMITH FALLS A6, K7A0A8. The company can be reached via phone at 855 558 9333 or via email at [email protected]

This page was last updated on 1/18/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.